about
Development of the follicular basement membrane during human gametogenesis and early folliculogenesisCD14(+) macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment areaOn the development of extragonadal and gonadal human germ cells.Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.Meiotic wave adds extra asymmetry to the development of female chicken gonads.Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA statusHigh and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.Cancer immunophenotyping by 7 colour multispectral imaging without tyramide signal amplificationEvidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancerEfficacy of PD-1 blockade in cervical cancer is related to a CD8FoxP3CD25 T-cell subset with operational effector functions despite high immune checkpoint levelsIndoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer.Adenocarcinoma of the uterine cervix shows impaired recruitment of cDC1 and CD8+ T cells and elevated β-Catenin activation compared to squamous cell carcinomaNeoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancerUnlocking the therapeutic potential of primary tumor-draining lymph nodes
P50
Q35016011-AAAF3DAB-83A9-48A2-AAB9-3BC502C9C829Q35799091-F591853F-A4A3-4CF3-BDA2-528086930FB5Q36544888-B8EB4EF0-AAFF-4DF0-92F8-4966858AA4B5Q36775097-B7C55443-9103-4C39-946D-3E6F6FEE5AE7Q37061685-1142CF9F-547A-44A1-A9A9-5A5D33D07FCEQ37279340-6F123F85-9E96-4D49-A0AA-3E187601B34CQ37414728-6C01D6BA-F2EF-474C-845A-A8289268EEF6Q37575182-980BE940-4307-44B8-AD18-94D9E955B1D8Q50773034-1B15C273-C55B-495C-B4C1-3BAC4EE7AA7BQ57159669-D2B1DFE8-09AB-4F44-9EC1-E99CFC502222Q59319960-C1AE7514-F772-484D-9EE7-EE560635A1DEQ64239710-A006F656-5E48-416B-A209-357C69339A25Q64923604-1DF5BF86-BAAA-496B-9731-057B9384E0ACQ90710891-CE3EC72B-1635-4FD0-9834-24CBF74A4894Q90736769-E2F91ABF-45AA-4597-A323-F4575B4C56E1Q92835077-9D816B56-B19E-4D49-8738-DAF37A929E99
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Marijne Heeren
@ast
A Marijne Heeren
@en
A Marijne Heeren
@es
A Marijne Heeren
@nl
type
label
A Marijne Heeren
@ast
A Marijne Heeren
@en
A Marijne Heeren
@es
A Marijne Heeren
@nl
prefLabel
A Marijne Heeren
@ast
A Marijne Heeren
@en
A Marijne Heeren
@es
A Marijne Heeren
@nl
P106
P1153
55307738400
P31
P496
0000-0002-4158-6058